Correction

Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

Richard W Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, Wen Jen Hwu, Jedd D. Wolchok, Anthony M. Joshua, Antoni Ribas, F. Stephen Hodi, Omid Hamid, Caroline Robert, Adil Daud, Roxana S Dronca, Peter Hersey, Jeffrey S. Weber, Amita Patnaik, Dinesh P. de Alwis, Andrea Perrone, Jin Zhang, S. Peter Kang, Scot Ebbinghaus & 2 others Keaven M. Anderson, Tara C. Gangadhar

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Abstract

In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume24
Issue number23
DOIs
StatePublished - Dec 1 2018

Fingerprint

Disclosure
Melanoma
Survival
Research
Neoplasms
pembrolizumab

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Correction : Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386). / Joseph, Richard W; Elassaiss-Schaap, Jeroen; Kefford, Richard; Hwu, Wen Jen; Wolchok, Jedd D.; Joshua, Anthony M.; Ribas, Antoni; Stephen Hodi, F.; Hamid, Omid; Robert, Caroline; Daud, Adil; Dronca, Roxana S; Hersey, Peter; Weber, Jeffrey S.; Patnaik, Amita; de Alwis, Dinesh P.; Perrone, Andrea; Zhang, Jin; Peter Kang, S.; Ebbinghaus, Scot; Anderson, Keaven M.; Gangadhar, Tara C.

In: Clinical Cancer Research, Vol. 24, No. 23, 01.12.2018.

Research output: Contribution to journalComment/debate

Joseph, RW, Elassaiss-Schaap, J, Kefford, R, Hwu, WJ, Wolchok, JD, Joshua, AM, Ribas, A, Stephen Hodi, F, Hamid, O, Robert, C, Daud, A, Dronca, RS, Hersey, P, Weber, JS, Patnaik, A, de Alwis, DP, Perrone, A, Zhang, J, Peter Kang, S, Ebbinghaus, S, Anderson, KM & Gangadhar, TC 2018, 'Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)', Clinical Cancer Research, vol. 24, no. 23. https://doi.org/10.1158/1078-0432.CCR-18-3340
Joseph, Richard W ; Elassaiss-Schaap, Jeroen ; Kefford, Richard ; Hwu, Wen Jen ; Wolchok, Jedd D. ; Joshua, Anthony M. ; Ribas, Antoni ; Stephen Hodi, F. ; Hamid, Omid ; Robert, Caroline ; Daud, Adil ; Dronca, Roxana S ; Hersey, Peter ; Weber, Jeffrey S. ; Patnaik, Amita ; de Alwis, Dinesh P. ; Perrone, Andrea ; Zhang, Jin ; Peter Kang, S. ; Ebbinghaus, Scot ; Anderson, Keaven M. ; Gangadhar, Tara C. / Correction : Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386). In: Clinical Cancer Research. 2018 ; Vol. 24, No. 23.
@article{6aa56a34b86246f9b0ee8c55ae46833e,
title = "Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)",
abstract = "In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.",
author = "Joseph, {Richard W} and Jeroen Elassaiss-Schaap and Richard Kefford and Hwu, {Wen Jen} and Wolchok, {Jedd D.} and Joshua, {Anthony M.} and Antoni Ribas and {Stephen Hodi}, F. and Omid Hamid and Caroline Robert and Adil Daud and Dronca, {Roxana S} and Peter Hersey and Weber, {Jeffrey S.} and Amita Patnaik and {de Alwis}, {Dinesh P.} and Andrea Perrone and Jin Zhang and {Peter Kang}, S. and Scot Ebbinghaus and Anderson, {Keaven M.} and Gangadhar, {Tara C.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1158/1078-0432.CCR-18-3340",
language = "English (US)",
volume = "24",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - Correction

T2 - Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

AU - Joseph, Richard W

AU - Elassaiss-Schaap, Jeroen

AU - Kefford, Richard

AU - Hwu, Wen Jen

AU - Wolchok, Jedd D.

AU - Joshua, Anthony M.

AU - Ribas, Antoni

AU - Stephen Hodi, F.

AU - Hamid, Omid

AU - Robert, Caroline

AU - Daud, Adil

AU - Dronca, Roxana S

AU - Hersey, Peter

AU - Weber, Jeffrey S.

AU - Patnaik, Amita

AU - de Alwis, Dinesh P.

AU - Perrone, Andrea

AU - Zhang, Jin

AU - Peter Kang, S.

AU - Ebbinghaus, Scot

AU - Anderson, Keaven M.

AU - Gangadhar, Tara C.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

AB - In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85057789854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057789854&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-18-3340

DO - 10.1158/1078-0432.CCR-18-3340

M3 - Comment/debate

VL - 24

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 23

ER -